Oncimmune Holdings (ONC)

29.00p
   
  • Change Today:
    -0.100p
  • 52 Week High: 40.50
  • 52 Week Low: 15.10
  • Currency: UK Pounds
  • Shares Issued: 74.14m
  • Volume: 20,505
  • Market Cap: £21.50m

ONC Overview

We are leaders in immune biomarkers; our vision is to enable personalised, data-driven clinical decisions across the cancer care continuum. Using our unique expertise and proprietary technology we aim to transform the way disease is diagnosed and treated around the world. We know that detecting the disease early can improve the ability to treat cancer and enhance chances of survival.

Key Personnel

CEO: Martin Gouldstone
Non-Executive Chairman: Alistair Macdonald
Senior Independent Non-Executive Director: Sally Waterman
Non-Executive Dir: John Goold

Contact Details

Address: MediCity – D6 Building, 1 Thane Road, Nottingham, United Kingdom, NG90 6BH
Phone: +44 1157 840 500
Website: http://oncimmune.com

Listings

Index: FTSE AIM All-Share
ISIN: GB00BYQ94H38

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ONC Market Data

Currency UK Pounds
Share Price 29.00p
Change Today -0.100p
% Change -0.34 %
52 Week High 40.50
52 Week Low 15.10
Volume 20,505
Shares Issued 74.14m
Market Cap £21.50m

ONC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

ONC Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
10:23 1,326 @ 27.48p
10:01 1,373 @ 27.48p
10:01 7,169 @ 27.83p
09:03 5,002 @ 29.00p
09:03 5,635 @ 29.00p

ONC Key Personnel

CEO Martin Gouldstone

Top of Page